Samer Tannus

ORCID: 0000-0002-4679-1851 · 5 papers in corpus · active 2009-2020

Study types

  • article 4
  • other 1

Condition tags

  • endometriosis 3
other 2020
Pretreatment with a gonadotropin-releasing hormone agonist and an aromatase inhibitor may improve outcomes in in vitro fertilization cycles of women with stage I-II endometriosis
F&S science ·doi:10.1016/j.xfss.2020.06.005

OBJECTIVE: To determine whether 2 months of pretreatment with 5 mg of letrozole daily plus leuprolide acetate at 3.75 mg monthly in women with laparoscopically confirmed American Society of Reproductive Medicine stage I-II endometriosis imp…

article 2019
Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure
Fertility and sterility ·doi:10.1016/j.fertnstert.2019.03.021
article 2018
A comparison of pre-treatment with and without GnRH-agonist or letrozole in women with 2 failed embryo transfers undergoing a frozen cycle and no evidence of endometriosis
·doi:10.1016/j.fertnstert.2018.07.557
article 2018
A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2018.12.028
article 2009
RETRACTED ARTICLE: Endometrial Cancer Presenting as Acute Urinary Retention: a Case Report and Review of the Literature
·doi:10.1186/1757-1626-2-9388

Abstract Introduction Endometrial cancer is the most common gynecologic malignancy. Most women present with abnormal vaginal bleeding. Cervical stenosis can prevent early uterine bleeding leading to delayed diagnosis of the disease. Case pr…